- Report
- November 2025
- 111 Pages
Europe
From €2435EUR$2,763USD£2,139GBP
€2865EUR$3,250USD£2,517GBP
- Report
- November 2025
- 101 Pages
Asia Pacific
From €2435EUR$2,763USD£2,139GBP
€2865EUR$3,250USD£2,517GBP
- Report
- November 2025
- 60 Pages
United States
From €1911EUR$2,168USD£1,678GBP
€2248EUR$2,550USD£1,975GBP
- Report
- November 2025
- 60 Pages
United States
From €1911EUR$2,168USD£1,678GBP
€2248EUR$2,550USD£1,975GBP
- Report
- November 2025
- 110 Pages
North America
From €2435EUR$2,763USD£2,139GBP
€2865EUR$3,250USD£2,517GBP
- Report
- November 2025
- 140 Pages
Europe
From €2435EUR$2,763USD£2,139GBP
€2865EUR$3,250USD£2,517GBP
- Report
- October 2025
- 84 Pages
Middle East
From €4276EUR$4,850USD£3,756GBP
- Report
- October 2025
- 90 Pages
North America
From €2435EUR$2,763USD£2,139GBP
€2865EUR$3,250USD£2,517GBP
- Report
- June 2025
- 89 Pages
North America
From €3042EUR$3,450USD£2,671GBP
- Report
- June 2025
- 81 Pages
Africa, Middle East
From €3042EUR$3,450USD£2,671GBP
- Report
- June 2025
- 97 Pages
Asia Pacific
From €3482EUR$3,950USD£3,059GBP
- Report
- June 2025
- 100 Pages
Europe
From €3482EUR$3,950USD£3,059GBP
- Report
- June 2025
- 90 Pages
United States
From €1410EUR$1,599USD£1,238GBP
€1762EUR$1,999USD£1,548GBP
- Report
- February 2025
- 95 Pages
North America
From €5285EUR$5,995USD£4,642GBP
- Report
- February 2025
- 111 Pages
Europe
From €5285EUR$5,995USD£4,642GBP
- Report
- February 2025
- 107 Pages
Asia Pacific
From €5285EUR$5,995USD£4,642GBP
- Report
- February 2025
- 236 Pages
United States
From €7049EUR$7,995USD£6,191GBP
- Report
- November 2023
- 127 Pages
Global
From €3967EUR$4,500USD£3,485GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €3174EUR$3,600USD£2,788GBP
- Report
- January 2023
- 127 Pages
Global
From €1984EUR$2,250USD£1,742GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more